Home»Exposition»Stone Capital Partners Biosyngen to Setup US$50 Million Biopharmaceutical Investment Fund in Singapore

Stone Capital Partners Biosyngen to Setup US$50 Million Biopharmaceutical Investment Fund in Singapore

0
Shares
Pinterest Google+
Stone Capital Partners Biosyngen to Setup US$50 Million Biopharmaceutical Investment Fund in Singapore

SINGAPORE, Nov. 10, 2019 /PRNewswire/ — Stone Capital and Biosyngen have partnered to establish a Biopharmaceutical Investment Fund in Singapore, the signing ceremony was held in Ascendas One Hub of Sino-Singapore Guangzhou Knowledge City. The key investment targets of the…

Previous post

SDRPY lancia il seminario saudita-yemenita

Next post

GÈNAVANT -- The Tailor-Made Jeweled Shoes Specialist Collaborates with Secoo to Promote Bespoke Elegance Online.